The use of menopause hormone therapy among women aged 40 to 74 rose from 2023 to 2026, suggests a study of a U.S. pharmacy database.
U.S. demand for menopause hormone therapy has more than doubled recently


The use of menopause hormone therapy among women aged 40 to 74 rose from 2023 to 2026, suggests a study of a U.S. pharmacy database.